ICD-10-CM E71.511 is the diagnosis code for Neonatal adrenoleukodystrophy. This code falls under the section "Metabolic disorders" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as E71.511. They are mutually exclusive:
Understanding where E71.511 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E71.511 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E71.511 is the ICD-10-CM diagnosis code for "Neonatal adrenoleukodystrophy". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E71.511 is E71.51 ("Disorders of peroxisome biogenesis"). E71.511 provides a more specific classification within this category.
E71.511 is located in Section E70-E88 — "Metabolic disorders" within Chapter 4 of the ICD-10-CM Tabular List.
Use E71.511 when the patients documented diagnosis matches "Neonatal adrenoleukodystrophy" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Neonatal adrenoleukodystrophy is E71.511.
Yes, E71.511 can be used as a primary diagnosis code since it is billable and specific.
E71.511 is in Chapter 4 of the ICD-10-CM Tabular List.
Type 1 Excludes for E71.511 include: X-linked adrenoleukodystrophy (E71.42-).
Yes, E71.511 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.